title: Elimination of glutathione-induced protection from hyperbaric hyperoxia by acivicin.
abstract: Glutathione (GSH) administered intraperitoneally significantly prolongs the time to initial seizure and survival time of rats exposed to hyperbaric hyperoxia (HBO). Acivicin is an antitumor antibiotic that is an inhibitor of gamma-glutamyl transpeptidase (GGT), an enzyme necessary for the breakdown and transport across cell membranes of GSH. To determine whether acivicin treatment alters GSH-induced protection from HBO, rats were dosed with 25 mg/kg of acivicin or vehicle 1 h before O2 exposure at an inspired O2 fraction of 1.0 at 4 ATA. Immediately before exposure, rats received GSH (1 mmol/kg) or vehicle. Time to seizure and time to death were recorded during exposure by direct observation. In separate groups of rats on the same dosing schedule, plasma GSH, renal GGT, and brain GGT were measured 15 min after the GSH injection without HBO exposure and 100 min after the beginning of HBO exposure. Renal GGT was decreased to 2.5% of control and brain GGT to 37% of control in the acivicin-dosed rats. Plasma GSH increased 3-fold in rats given acivicin alone, 52-fold in rats given GSH alone, and 84-fold in rats receiving both acivicin and GSH. Rats dosed with GSH alone had significantly prolonged times to seizure and death compared with all other groups. Rats dosed with GSH after receiving acivicin were not protected from HBO despite the large increase in plasma GSH that occurred in these animals. GSH treatment did not increase tissue GSH in lung, liver, or brain at 160 or 200 min of exposure.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Lung Metabolic Unit, University of Texas Health Science Center at San Antonio.
authors.forename: M D
authors.initials: MD
authors.lastname: Peacock
authors.forename: D A
authors.initials: DA
authors.lastname: Schenk
authors.forename: R A
authors.initials: RA
authors.lastname: Lawrence
authors.forename: J A
authors.initials: JA
authors.lastname: Morgan
authors.forename: S G
authors.initials: SG
authors.lastname: Jenkinson
mesh_terms: D000818:Animals; D001921:Brain / Q000201:enzymology; D001923:Brain Chemistry / Q000187:drug effects; D005978:Glutathione / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000494:pharmacology; D006931:Hyperbaric Oxygenation / Q000009:adverse effects*; D007555:Isoxazoles / Q000494:pharmacology*; D007668:Kidney / Q000201:enzymology / Q000378:metabolism; D008168:Lung / Q000201:enzymology / Q000378:metabolism; D008297:Male; D010100:Oxygen / Q000037:antagonists & inhibitors* / Q000633:toxicity; D051381:Rats; D017207:Rats, Sprague-Dawley; D012640:Seizures / Q000139:chemically induced / Q000517:prevention & control; D005723:gamma-Glutamyltransferase / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D007555:Isoxazoles; D005723:gamma-Glutamyltransferase; D005978:Glutathione; C006303:acivicin; D010100:Oxygen